|
|
|
| Webinar: AAV Analytics: Key Considerations When Developing A Clinical Program | Challenges like inadequate analytical development can stall an advanced therapy's development. At Andelyn, method validation has been integral to our processes. We develop assays from our research to meet the standards of large-scale GMP production of plasmids and viral vectors. Please join Andelyn to learn key considerations for taking your AAV gene therapy from concept to commercialization with advanced analytics. Click here to learn more. |
|
|
|
|
By Life Science Connect Editorial Staff | Sam Deutsch of Nutcracker Therapeutics and Nathaniel Wang of Replicate Bioscience discuss RNA therapies, shedding light on tissue specificity, potency, and the evolving landscape of RNA engineering. |
|
|
|
The more data at your disposal, the richer the input for your analytical algorithms. This leads to more dependable outcomes. Seize the opportunity to leverage data for enhanced decision-making and drive success in your endeavors. |
|
|
|
| To GMP Or Not To GMP? That Is The (Plasmid) Question | Article | By Eric Gudorf and Erika Morris, Ajinomoto Bio-Pharma Services | As critical raw materials for viral vector production, plasmids are in high demand. Finding an experienced, GMP-grade plasmid supplier for your process can mitigate risk and yield reliable results. |
|
|
| Scaling Up Strategy For Oncolytic HSV-1 Vector Manufacturing | Case Study | By Lingjing Tang, Jun Wang, Shiyi Mei, Zhengrui Xiong, Zihao Fang, Han Gao, Houliang Wei, and Weiran Shen, OBiO Tech | Discover how a novel, large-scale production method for herpes simplex virus type-1 (HSV-1) vectors has the potential to accelerate gene therapy progress and widespread application. |
|
|
|
| Scalable Suspension LVV Production Platforms | Webinar | Lonza | Review a scalable suspension-based Lenti production platform using a proprietary HEK293T clonal cell line and improvement steps to generate commercially viable therapies from concept to patient. |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
